KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Raw Materials (2016 - 2019)

Pfizer (PFE) has disclosed Raw Materials for 11 consecutive years, with $560.0 million as the latest value for Q1 2019.

  • Quarterly Raw Materials fell 32.12% to $560.0 million in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $560.0 million through Mar 2019, down 32.12% year-over-year, with the annual reading at $546.0 million for FY2018, 30.71% down from the prior year.
  • Raw Materials for Q1 2019 was $560.0 million at Pfizer, up from $546.0 million in the prior quarter.
  • The five-year high for Raw Materials was $950.0 million in Q3 2016, with the low at $475.0 million in Q1 2015.
  • Average Raw Materials over 5 years is $754.1 million, with a median of $809.0 million recorded in 2016.
  • The sharpest move saw Raw Materials soared 84.82% in 2016, then plummeted 32.12% in 2019.
  • Over 5 years, Raw Materials stood at $867.0 million in 2015, then dropped by 8.54% to $793.0 million in 2016, then dropped by 0.63% to $788.0 million in 2017, then plummeted by 30.71% to $546.0 million in 2018, then grew by 2.56% to $560.0 million in 2019.
  • According to Business Quant data, Raw Materials over the past three periods came in at $560.0 million, $546.0 million, and $839.0 million for Q1 2019, Q4 2018, and Q3 2018 respectively.